Wholesale
Wholesale pricing available
Qualify for automatic discounts at checkout when your order of wholesale eligible items hits a volume threshold.
$2,000+15% off$4,000+20% off$6,000+25% off$10,000+40% offFull wholesale details →
$654.60$689.05
($130.92 / Item) — Save $34.45 (5% off)
In stock — dispatches within 24h, tracked
Semaglutide 5mg. Used to support weight management, appetite control, reduced food cravings, and improved blood sugar control. Lab tested, discreetly shipped across Canada.
FormatLyophilized Vial
ConcentrationDepends on reconstitution with BAC water
Pack Size Selected: 5 Pack
Pay with Interac e-Transfer or Crypto
Ships from within Canada; No Customs
Discreet plain packaging; always
24h dispatch; Tracked Delivery
Semaglutide is a long acting synthetic GLP-1 receptor agonist with a half-life of approximately 7 days, achieved through fatty acid chain conjugation enabling albumin binding and protection against DPP-4 enzymatic degradation. iLab Pharma’s 5mg lyophilized vial sits between the existing 10mg iLab Pharma lyophilized vial and the pen format presentations in CSD’s Semaglutide range. Providing a mid range reconstitute vial option for researchers requiring less total compound than the 10mg vial supplies or greater dosing flexibility than the fixed and adjustable pen formats accommodate.
The 5mg lyophilized vial format serves a distinct research purpose within CSD’s Semaglutide vial range. The 10mg iLab Pharma vial suits extended protocols and multi group experimental designs requiring significant compound availability from a single source. The 5mg format targets shorter duration protocols, initial compound evaluation before committing to larger supply volumes, or research designs where precise low to mid range reconstitution concentration control is the priority variable. At 5mg total this vial provides half the compound per unit of the 10mg vial while maintaining the same reconstitute format advantages. Researcher controlled concentration preparation, in vitro research applicability, and parenteral administration flexibility that pen delivery systems cannot accommodate.
CSD’s Semaglutide range now spans six distinct presentations, the 2mg adjustable single pen, the 4mg adjustable pen in generic and F40 Biotech variants, the 9.6mg fixed dose prefilled pen, this 5mg iLab Pharma lyophilized vial, and the 10mg iLab Pharma lyophilized vial. Covering every Semaglutide concentration and format requirement across pen and vial delivery systems from a single verified Canadian supplier. The pure GLP-1 receptor selectivity of Semaglutide remains consistent across all presentations, maintaining its position as the single receptor reference standard against which CSD’s dual and triple incretin agonist listings are compared in comparative receptor pathway research.
iLab Pharma formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COC documentation available on request. CSD’s sourcing standards apply uniformly across all manufacturers we carry, and iLab Pharma’s Semaglutide 5mg meets those standards consistently. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.
Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.
Commonly researched alongside dual and triple incretin agonist compounds in comparative GLP-1 receptor pathway and metabolic activity studies. Browse CSD’s full peptide range for complete sourcing.
Semaglutide is a long acting peptide analogue of glucagon like peptide 1 (GLP-1) that activates the GLP-1 receptor. It has been extensively studied for its effects on glucose regulation, insulin secretion, appetite signaling, gastric emptying, body weight regulation, and broader cardiometabolic function. This product contains 5mg of lyophilized Semaglutide in a single vial for laboratory research.
Semaglutide has been extensively investigated in research involving type 2 diabetes, obesity, body weight regulation, appetite, glucose metabolism, cardiovascular outcomes, and metabolic health. GLP-1 receptor activation influences several physiological pathways involved in glucose dependent insulin secretion, glucagon regulation, food intake, and gastrointestinal function.
Semaglutide acts as an agonist at the GLP-1 receptor, reproducing key biological actions of the naturally occurring incretin hormone GLP-1. Receptor activation increases glucose dependent insulin secretion, reduces inappropriate glucagon secretion when glucose is elevated, influences appetite and food intake signaling, and delays gastric emptying. Semaglutide is structurally modified to resist rapid degradation and maintain a substantially longer duration of exposure than native GLP-1.
The primary difference is receptor activity. Semaglutide primarily activates the GLP-1 receptor. Tirzepatide activates both GIP and GLP-1 receptors, while retatrutide activates GIP, GLP-1, and glucagon receptors. Semaglutide therefore represents a single receptor GLP-1 approach compared with the dual and triple receptor mechanisms of tirzepatide and retatrutide.
Yes! This batch is HPLC tested to verify Semaglutide identity and content accuracy at 5mg per vial. A certificate of analysis is available.
